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Ganoderma lucidum is one of the most extensively studied mushroom species due to its 
medicinal properties. It has been used as functional food and as chemopreventer in 
some countries for thousands of years, and became a popular dietary supplement 
ingredient in Western countries [1]. Some of its pharmacological properties have been 
related to antitumour properties, attributed to a wide variety of bioactive components 
such as polysaccharides, triterpenes, sterols, lectins and some proteins [2,3]. 
Nevertheless, the bioactive properties of its phenolic compounds have not been studied. 
The aim of this work was to study the potential antitumor activity of the methanolic 
extract of this mushroom. This extract of Ganoderma lucidum, collected in Northeast 
Portugal, was characterized in phenolic compounds, by high performance liquid 
chromatography coupled to photodiode array detection and mass spectrometry (HPLC-
DAD-MS). The extract was further submitted to evaluation of growth inhibitory activity 
in four human tumour cell lines (MCF-7, NCI-H460, HCT15 and AGS), by the 
sulforhodamine B assay. 
The extract presented a moderate growth inhibitory activity in all the cell lines tested 
(values of GI50 between 93.3±18.1 and 112.6±11.7µg/mL).The following compounds 
were identified in the extract: p-hydroxybenzoic acid (0.58 ± 0.04 mg/100 g dw), p-
coumaric acid (0.38 ± 0.03 mg/100 g dw) and cinnamic acid (0.28 ± 0.03 mg/100 g dw). 
Future work will elucidate the mechanism of action of the studied extract leading to the 
observed cell growth inhibition. 
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